☆ 4.6 Review

Prognostic scores in heart failure - Critical appraisal and practical use

INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)

期刊

INTERNATIONAL JOURNAL OF CARDIOLOGY

卷 188, 期 -, 页码 1-9

出版社

ELSEVIER IRELAND LTD

DOI: 10.1016/j.ijcard.2015.03.154

关键词

Heart failure; Prognosis; Outcomes

类别

Cardiac & Cardiovascular Systems

资金

Fondazione Credito Bergamasco (CREBERG)

向作者/读者索取更多资源

Protocol

Reagent

摘要

Survival in patients with heart failure in the last two decades has significantly improved, owing to availability of new drugs, devices, and technologies. However, these new therapeutic tools are often costly and not without attendant risks. Thus, accurate and reproducible risk stratification is required to assess appropriateness of therapy. Although a growing body of evidence has characterized various predictors of poor outcomes, the application of comprehensive prognostic models in clinical practice remains limited. Herein, we critically evaluate the utility of prognostic scores in heart failure, discussing the strategies to select the most efficient and appropriate risk estimator in the individual patient. (C) 2015 Elsevier Ireland Ltd. All rights reserved.

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Endocrinology & Metabolism

Association between prediabetes and adverse outcomes in heart failure

Linlin Mai, Weixing Wen, Min Qiu, Xiong Liu, Lichang Sun, Haoxiao Zheng, Xiaoyan Cai, Yuli Huang

Summary: Patients with heart failure and prediabetes have a higher risk of all-cause mortality and adverse cardiac outcomes compared to those without prediabetes. Further risk stratification and effective treatment strategies are needed to improve the prognosis in these patients.

DIABETES OBESITY & METABOLISM (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Association of Hyper-Polypharmacy With Clinical Outcomes in Heart Failure With Preserved Ejection Fraction

Masatoshi Minamisawa, Brian Claggett, Kota Suzuki, Sheila M. Hegde, Amil M. Shah, Akshay S. Desai, Eldrin F. Lewis, Sanjiv J. Shah, Nancy K. Sweitzer, James C. Fang, Inder S. Anand, Eileen O'Meara, Jean-Lucien Rouleau, Bertram Pitt, Marc A. Pfeffer, Scott D. Solomon, Orly Vardeny

Summary: The study revealed that hyper-polypharmacy was associated with an elevated risk of hospitalization for any reason and any serious adverse events in patients with heart failure with preserved ejection fraction, but not significantly associated with mortality.

CIRCULATION-HEART FAILURE (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Long-Term Clinical Outcomes in Patients With Severe Tricuspid Regurgitation

Naoki Nishiura, Takeshi Kitai, Taiji Okada, Madoka Sano, Norihisa Miyawaki, Kitae Kim, Ryosuke Murai, Toshiaki Toyota, Yasuhiro Sasaki, Natsuhiko Ehara, Atsushi Kobori, Makoto Kinoshita, Tadaaki Koyama, Yutaka Furukawa

Summary: This study aimed to investigate the natural history and optimal interventional timing in patients with isolated severe tricuspid regurgitation (TR). The results showed that TR pressure gradient, blood urea nitrogen, left atrial volume index, and serum albumin were independent predictors of adverse events. The prognosis of isolated severe TR is not always favorable, and careful attention should be paid to patients with concomitant risk factors.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Comparison of Soluble ST2, Pentraxin-3, Galectin-3, and High-Sensitivity Troponin T of Cardiovascular Outcomes in Patients With Acute Decompensated Heart Failure

Masayoshi Yamamoto, Yoshihiro Seo, Tomoko Ishizua, Daishi Nakagawa, Kimi Sato, Tomoko Machino-Ohtsuka, Isao Nishi, Yoshie Hamada-Harimura, Seika Sai, Akinori Sugano, Masako Baba, Haruhiko Higuchi, Kazutaka Aonuma, Nobuyuki Ohte, Masaki Ieda

Summary: This study showed that sST2 can predict cardiovascular events in patients with heart failure, especially in those with preserved ejection fraction. Other biomarkers such as PTX3, Gal-3, and high-sensitivity troponin T did not demonstrate significant predictive value after adjustment for clinical variables.

JOURNAL OF CARDIAC FAILURE (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Elevated serum albumin-to-creatinine ratio as a protective factor on outcomes after heart transplantation

Qiang Shen, Dingyi Yao, Yang Zhao, Xingyu Qian, Yidan Zheng, Li Xu, Chen Jiang, Qiang Zheng, Si Chen, Jiawei Shi, Nianguo Dong

Summary: This study investigated the prognostic significance of serum albumin to creatinine ratio (ACR) in patients receiving heart transplantation for end-stage heart failure. The findings suggest that ACR is a favorable prognostic indicator in heart transplantation patients.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2023)

添加到收藏夹

Article Medicine, General & Internal

Retinal Microvascular Abnormalities Predict Clinical Outcomes in Patients with Heart Failure

Shaohua Guo, Songtao Yin, Wenhua Song, Gary Tse, Juping Liu, Kaiwen Hei, Kangyin Chen, Long Su, Tong Liu

Summary: Narrower retinal arterioles and wider retinal venules have been associated with the incidence of heart failure. This study found that when retinal venular caliber widens to a certain point, the incidence of HF rehospitalization and mortality significantly increases.

DIAGNOSTICS (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Cardiac Power Output Is Independently and Incrementally Associated With Adverse Outcomes in Heart Failure With Preserved Ejection Fraction

Tomonari Harada, Miho Yamaguchi, Kazunori Omote, Hiroyuki Iwano, Yoshifumi Mizuguchi, Shiro Amanai, Kuniko Yoshida, Toshimitsu Kato, Koji Kurosawa, Toshiyuki Nagai, Kazuaki Negishi, Toshihisa Anzai, Masaru Obokata

Summary: In patients with heart failure with preserved ejection fraction, cardiac power output is independently and incrementally associated with adverse outcomes, while other markers of cardiac performance are not.

CIRCULATION-CARDIOVASCULAR IMAGING (2022)

添加到收藏夹

Article Surgery

Perioperative Renin-Angiotensin System Inhibitors Improve Major Outcomes of Heart Failure Patients Undergoing Cardiac Surgery A Propensity-Adjusted Cohort Study

Yan-Qing Zhang, Xiao-Gang Liu, Qian Ding, Mark Berguson, Rohinton J. Morris, Hong Liu, Jordan E. Goldhammer

Summary: The study aimed to investigate the association between perioperative administration of renin angiotensin system inhibitors (RASi) and clinical outcomes in heart failure patients undergoing cardiac surgery. The results showed that perioperative use of RASi was associated with lower short-term mortality, stroke, and renal failure rates. Additionally, both preoperative continuation and postoperative use of RASi were associated with reduced 6-year mortality.

ANNALS OF SURGERY (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure

Michael J. Mack, JoAnn Lindenfeld, William T. Abraham, Saibal Kar, D. Scott Lim, Jacob M. Mishell, Brian K. Whisenant, Paul A. Grayburn, Michael J. Rinaldi, Samir R. Kapadia, Vivek Rajagopal, Ian J. Sarembock, Andreas Brieke, Jason H. Rogers, Steven O. Marx, David J. Cohen, Neil J. Weissman, Gregg W. Stone

Summary: This study demonstrated that among patients with heart failure and mitral regurgitation, transcatheter mitral valve repair (TMVr) provided effective and sustained reduction in heart failure hospitalizations, mortality, and improved quality of life and functional capacity compared to guideline-directed medical therapy alone through 36 months. Additionally, patients who crossed over to TMVr treatment after 24 months also experienced significant benefits in terms of reduced mortality and heart failure hospitalizations.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Renal Venous Stasis Index Reflects Renal Congestion and Predicts Adverse Outcomes in Patients With Heart Failure

Himika Ohara, Akiomi Yoshihisa, Yuko Horikoshi, Shinji Ishibashi, Mitsuko Matsuda, Yukio Yamadera, Yukiko Sugawara, Yasuhiro Ichijo, Yu Hotsuki, Koichiro Watanabe, Yu Sato, Tomofumi Misaka, Takashi Kaneshiro, Masayoshi Oikawa, Atsushi Kobayashi, Yasuchika Takeishi

Summary: The renal venous stasis index (RVSI) assessed by renal Doppler ultrasonography is associated with parameters of cardiac function and right heart catheterization (RHC) in patients with heart failure (HF), and is also linked to adverse prognosis.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

添加到收藏夹

Article Peripheral Vascular Disease

Adverse Health Outcomes Associated With Refractory and Treatment-Resistant Hypertension in the Chronic Renal Insufficiency Cohort

Michael G. Buhnerkempe, Vivek Prakash, Albert Botchway, Bemi Adekola, Jordana B. Cohen, Mahboob Rahman, Matthew R. Weir, Ana C. Ricardo, John M. Flack

Summary: The study showed that refractory hypertension (RfH) is associated with worse long-term health outcomes compared with treatment-resistant hypertension (TRH), including worsening renal and cardiovascular outcomes. However, there was no significant difference in the all-cause mortality between individuals with RfH and TRH.

HYPERTENSION (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Right Heart Failure Following Left Ventricular Device Implantation: Natural History, Risk Factors, and Outcomes: An Analysis of the STS INTERMACS Database

Chris J. Kapelios, Lars H. Lund, Omar Wever-Pinzon, Craig H. Selzman, Susan L. Myers, Ryan S. Cantor, Josef Stehlik, Themistocles Chamogeorgakis, Stephen H. McKellar, Antigone Koliopoulou, Rami Alharethi, Abdallah G. Kfoury, Michael Bonios, Stamatis Adamopoulos, Edward M. Gilbert, James C. Fang, James K. Kirklin, Stavros G. Drakos

Summary: Right heart failure (RHF) after left ventricular assist device (LVAD) is a common and frequently transient condition, with de novo, late RHF (>6 months) being more frequently a persistent disorder associated with increased mortality. Several risk factors, such as higher preimplant blood urea nitrogen levels, previous tricuspid valve repair/replacement, severely depressed right ventricular systolic function, and centrifugal LVAD, are associated with an increased incidence of RHF. Patients with persistent RHF at 3 months have the lowest 2-year survival, while patients with de novo RHF or RHF that resolves by 3 months have more favorable survival outcomes.

CIRCULATION-HEART FAILURE (2022)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Liver stiffness assessed by magnetic resonance elastography predicts clinical outcomes in patients with heart failure and without chronic liver disease

Atsushi Tada, Toshiyuki Nagai, Yoshiya Kato, Kazunori Omote, Noriko Oyama-Manabe, Satonori Tsuneta, Yusuke Kudo, Mutsumi Nishida, Michikazu Nakai, Yuki Takahashi, Kohei Saiin, Seiichiro Naito, Yuta Kobayashi, Sakae Takenaka, Yoshifumi Mizuguchi, Kiwamu Kamiya, Takao Konishi, Takuma Sato, Kohsuke Kudo, Toshihisa Anzai

Summary: Liver stiffness measured by MRE is a predictor of clinical outcomes in patients with heart failure, independent of liver disease.

EUROPEAN RADIOLOGY (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Changing Demographics, Temporal Trends in Waitlist, and Posttransplant Outcomes After Heart Transplantation in the United States: Analysis of the UNOS Database 1991-2019

Emmanuel Akintoye, Paulino Alvarez, Doosup Shin, Alexander Egbe, Anthony Panos, Frank Sellke, Alexandros Briasoulis

Summary: The study revealed that patients listed for heart transplantation between 1991 and 2019 were older with higher risk comorbidities. While the transplant volume increased, there remained a supply-demand gap, but recent policy changes successfully reduced waitlist mortality.

CIRCULATION-HEART FAILURE (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Clinical characteristics, predictors, and outcomes of heart failure with improved ejection fraction

Kangkang Su, Mingquan Li, Lili Wang, Shipeng Tian, Jingjing Su, Jian Gu, Shuxia Chen

Summary: This study analyzed a subset of heart failure patients who showed improvement in ejection fraction and compared them with other heart failure phenotypes. The results showed that patients with improved ejection fraction had a prognosis similar to those with mid-range ejection fraction, and superior to those with preserved ejection fraction and reduced ejection fraction. Valve heart disease and anemia increased the risk of endpoint events in these patients.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Epidemiology and Outcomes of Aortic Stenosis in Acute Decompensated Heart Failure: The ARIC Study

Krishan Sivaraj, Sameer Arora, Michael Hendrickson, Trisha Slehria, Patricia P. Chang, Thelsa Weickert, Muthiah Vaduganathan, Arman Qamar, Ambarish Pandey, Melissa C. Caughey, Matthew A. Cavender, Wayne Rosamond, John P. Vavalle

Summary: This study investigated the epidemiology and outcomes of aortic stenosis (AS) in acute decompensated heart failure (ADHF) patients. The results showed that AS is prevalent and independently associated with 1-year mortality in this high-risk population.

CIRCULATION-HEART FAILURE (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Serial troponin-T and long-term outcomes in suspected acute coronary syndrome

Manan Pareek, Kristian H. Kragholm, Anna Meta Dyrvig Kristensen, Muthiah Vaduganathan, Jannik L. Pallisgaard, Christina Byrne, Tor Biering-Sorensen, Christina Ji-Young Lee, Anders Nissen Bonde, Martin Bodtker Mortensen, Michael Maeng, Emil L. Fosbol, Lars Kober, Niels Thue Olsen, Gunnar H. Gislason, Deepak L. Bhatt, Christian Torp-Pedersen

Summary: The study found that individuals suspected of acute coronary syndrome who had consecutively elevated high-sensitivity troponin concentrations had the highest risk of death, while those with consecutively normal hsTnT concentrations had very low mortality rates, regardless of changes between measurements.

EUROPEAN HEART JOURNAL (2023)

添加到收藏夹

Article Transplantation

Non-steroidal mineralocorticoid receptor antagonists and cardiorenal outcomes in chronic kidney disease

Kevin Bryan Lo, Janani Rangaswami, Muthiah Vaduganathan

Summary: The burden of adverse cardiorenal outcomes among patients with diabetes, heart failure, and chronic kidney disease remains high. Steroidal mineralocorticoid receptor antagonists (MRAs) have been shown to improve clinical outcomes in heart failure patients, but are underutilized, especially in advanced CKD. Non-steroidal MRAs are a new therapeutic option for patients with diabetic kidney disease and have been supported by guidelines. They have a unique pharmacological profile that retains cardiorenal benefits but may help mitigate adverse effects in CKD patients, including hyperkalemia. This review summarizes the current evidence on the use of non-steroidal MRAs in improving cardiorenal outcomes in patients with CKD and diabetes, as well as their combination use with other foundational therapies in heart failure and CKD.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Effect of Electronic Nudges on Influenza Vaccination Rate in Older Adults With Cardiovascular Disease: Prespecified Analysis of the NUDGE-FLU Trial

Daniel Modin, Niklas Dyrby Johansen, Muthiah Vaduganathan, Ankeet S. Bhatt, Simin Gharib Lee, Brian L. Claggett, Erica L. Dueger, Sandrine I. Samson, Matthew M. Loiacono, Lars Kober, Scott D. Solomon, Pradeesh Sivapalan, Jens Ulrik Staehr Jensen, Cyril Jean-Marie Martel, Palle Valentiner-Branth, Tyra Grove Krause, Tor Biering-Sorensen

Summary: Digital behavioral nudges, such as electronic letters, emphasizing the potential cardiovascular benefits of influenza vaccination and using a reminder letter strategy, were found to be effective in increasing influenza vaccine uptake among older adults both with and without cardiovascular disease.

CIRCULATION (2023)

添加到收藏夹

Letter Cardiac & Cardiovascular Systems

Risk of Incident Thromboembolic and Ischemic Events After COVID-19 Vaccination Compared With SARS-CoV-2 Infection

Mats C. Hojbjerg Lassen, Daniel Modin, Kristoffer Grundtvig Skaarup, Niklas Dyrby Johansen, Brian Claggett, Scott D. Solomon, Michael Fralick, Jens Ulrik Staehr Jensen, Pradeesh Sivapalan, Muthiah Vaduganathan, Manan Pareek, Morten Schou, Tyra Grove Krause, Anders Hviid, Lars Kober, Christian Torp-Pedersen, Gunnar Gislason, Tor Biering-Sorensen

CIRCULATION (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF

Muthiah Vaduganathan, Robert J. Mentz, Brian L. Claggett, Zi Michael Miao, Ian J. Kulac, Jonathan H. Ward, Adrian F. Hernandez, David A. Morrow, Randall C. Starling, Eric J. Velazquez, Kristin M. Williamson, Akshay S. Desai, Shelley Zieroth, Martin Lefkowitz, John J. McMurray, Eugene Braunwald, Scott D. Solomon

Summary: Pooled analyses of PARAGLIDE-HF and PARAGON-HF demonstrate that sacubitril/valsartan can significantly reduce the risk of heart failure exacerbation and cardiovascular and renal events in patients with heart failure. These data support the use of sacubitril/valsartan in patients with heart failure, particularly those with mildly reduced or preserved ejection fraction.

EUROPEAN HEART JOURNAL (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Importance of cystatin C in estimating glomerular filtration rate: the PARADIGM-HF trial

Paolo Tolomeo, Jawad H. Butt, Toru Kondo, Gianluca Campo, Akshay S. Desai, Pardeep S. Jhund, Lars Kober, Martin P. Lefkowitz, Jean L. Rouleau, Scott D. Solomon, Karl Swedberg, Muthiah Vaduganathan, Michael R. Zile, Milton Packer, John J. McMurray

Summary: The 2021 CKD-EPI equation combining creatinine and cystatin C provides a better estimation of GFR compared to the creatinine-only equation. The creatinine-cystatin equation led to a substantial reclassification of chronic kidney disease stages and was associated with higher mortality and worsening of clinical scores in heart failure patients.

EUROPEAN HEART JOURNAL (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Sodium-glucose cotransporter 2 inhibitors vs. sitagliptin in heart failure and type 2 diabetes: an observational cohort study

Edouard L. Fu, Elisabetta Patorno, Brendan M. Everett, Muthiah Vaduganathan, Scott D. Solomon, Raisa Levin, Sebastian Schneeweiss, Rishi J. Desai

Summary: This study aimed to evaluate the comparative effectiveness of SGLT2i vs. sitagliptin in older adults with HF and type 2 diabetes and found that initiating SGLT2i was associated with a lower risk of the primary composite outcome compared to sitagliptin.

EUROPEAN HEART JOURNAL (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials

Robert A. Fletcher, Clare Arnott, Patrick Rockenschaub, Aletta E. Schutte, Lewis Carpenter, Muthiah Vaduganathan, Rajiv Agarwal, George Bakris, Tara I. Chang, Hiddo J. L. Heerspink, Meg J. Jardine, Kenneth W. Mahaffey, Bruce Neal, Carol Pollock, Min Jun, Anthony Rodgers, Vlado Perkovic, Brendon L. Neuen

Summary: Using data from CANVAS and CREDENCE trials, this study found that visit-to-visit blood pressure variability is independently associated with the risks of hospitalization for heart failure and all-cause mortality in patients with type 2 diabetes and high cardiovascular risk or chronic kidney disease. However, the use of canagliflozin has little to no effect on blood pressure variability.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Impact of Diabetes on Outcomes in Patients Hospitalized With Acute Myocardial Infarction: Insights From the Atherosclerosis Risk in Communities Study Community Surveillance

Vardhmaan Jain, Arman Qamar, Kunihiro Matsushita, Muthiah Vaduganathan, Kellan E. Ashley, Muhammad Shahzeb Khan, Deepak L. Bhatt, Sameer Arora, Melissa C. Caughey

Summary: Diabetes is associated with a higher risk of death in patients hospitalized with acute myocardial infarction (AMI), with increasing prevalence of diabetes over time. Patients with diabetes were older, more often Black, and more commonly women. They had higher comorbidities and presented differently compared to patients without diabetes. They also had lower probabilities of receiving certain therapies and higher 1-year mortality risk.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

添加到收藏夹

Article Medicine, General & Internal

Lipoprotein (a), Inflammation, and Atherosclerosis

Stefania Angela Di Fusco, Aldo Pietro Maggioni, Pietro Scicchitano, Marco Zuin, Emilia D'Elia, Furio Colivicchi

Summary: Growing evidence suggests that high levels of lipoprotein (a) (Lp(a)) and chronic inflammation contribute to the residual risk of cardiovascular events. Studies have found that elevated Lp(a) levels are associated with various atherosclerotic diseases, including ischemic heart disease, stroke, and calcific aortic stenosis. Current lipid-lowering drugs have limited effect on Lp(a) levels, while chronic inflammation, indicated by high sensitivity C reactive protein levels, further increases cardiovascular risk. Anti-inflammatory drugs such as canakinumab and colchicine have shown promise in reducing cardiovascular risk. Ongoing research to improve risk stratification and develop targeted diagnostic and therapeutic strategies is important for managing atherosclerotic cardiovascular disease.

JOURNAL OF CLINICAL MEDICINE (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial

John W. Ostrominski, Muthiah Vaduganathan, Senthil Selvaraj, Brian L. Claggett, Zi Michael Miao, Akshay S. Desai, Pardeep S. Jhund, Mikhail N. Kosiborod, Carolyn S. P. Lam, Silvio E. Inzucchi, Felipe A. Martinez, Rudolf A. de Boer, Adrian F. Hernandez, Sanjiv J. Shah, Magnus Petersson, Anna Maria Langkilde, John J. V. Mcmurray, Scott D. Solomon

Summary: This study analyzed the potential role of dapagliflozin in treating apparent treatment-resistant hypertension (aTRH) in heart failure patients. The results showed that dapagliflozin consistently improved cardiovascular outcomes and was well-tolerated in patients with aTRH.

CIRCULATION (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Cardiorenal Biomarkers, Canagliflozin, and Outcomes in Diabetic Kidney Disease: The CREDENCE Trial

James L. Januzzi, Reza Mohebi, Yuxi Liu, Naveed Sattar, Hiddo J. L. Heerspink, Eshetu Tefera, Muthiah Vaduganathan, Javed Butler, Yshai Yavin, Jingwei Li, Carol A. Pollock, Vlado Perkovic, Bruce Neal, Michael K. Hansen

Summary: Multiple cardiorenal stress biomarkers are strongly prognostic in people with type 2 diabetes and albuminuria. Canagliflozin modestly reduced the longitudinal trajectory of rise in each biomarker. Change in the biomarker level in addition to the baseline level augments the primary outcome prediction.

CIRCULATION (2023)

添加到收藏夹

Article Endocrinology & Metabolism

Estimated lifetime benefit of novel pharmacological therapies in patients with type 2 diabetes and chronic kidney disease: A joint analysis of randomized controlled clinical trials

Hiddo J. L. Heerspink, Priya Vart, Niels Jongs, Brendon L. Neuen, George Bakris, Brian Claggett, Muthiah Vaduganathan, Finnian McCausland, Kieran F. Docherty, Pardeep S. Jhund, Scott D. Solomon, Vlado Perkovic, John J. V. McMurray

Summary: The combination treatment of SGLT2 inhibitors and MRA in patients with type 2 diabetes and CKD can significantly extend event-free survival and overall survival, with an estimated gain of 6.7 years in event-free survival compared to ACE inhibitors/angiotensin receptor blockers. This conclusion is supported by both trial data and observational study results. Even in a conservative scenario, the combination therapy still provides a substantial gain of 2.5 years in event-free survival.

DIABETES OBESITY & METABOLISM (2023)

添加到收藏夹

Article Urology & Nephrology

Effects of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients with Chronic Kidney Disease: The DECODE-CKD Trial

Katja Vu Bartholdy, Niklas Dyrby Johansen, Nino Landler, Kristoffer Grundtvig Skaarup, Jesper Jensen, Iain Bressendorff, Morten Schou, Jacob Christensen, Bo Feldt-Rasmussen, Muthiah Vaduganathan, Scott Solomon, Richard Haynes, Frederik Persson, Peter Rossing, Lars Kober, Faiez Zannad, Ditte Hansen, Tor Biering-Sorensen

Summary: This study aims to evaluate the effects of SGLT2 inhibitors on cardiac structure and function in patients with CKD. The results will provide insights into the cardioprotective mechanisms of SGLT2 inhibitors in patients with CKD.

KIDNEY360 (2023)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.